An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Journal of Applied Medical Sciences | Volume-5 | Issue-07
Clinical Study of Microvascular Complications in Type 2 Diabetics Less Than 50 Years of Age With Reference To the Glycated Hemoglobin Level in a Tertiary Care Centre in Rewa
Dr. Anurag Chaurasia , Dr. Manish Kumar
Published: July 30, 2017 | 155 139
DOI: 10.36347/sjams.2017.v05i07.026
Pages: 2625-2629
Downloads
Abstract
Diabetes mellitus ranks twelfth in all-cause mortality worldwide. Many of preventable complications of Diabetes flare up in young but due to the silent nature of the disease these are diagnosed late. These complications are attributed to the involvement of microvasculature of target organs. Hence we decided to explore relation of glycemic control and frequency of various complications among the young diabetic population which is useful in preventing Diabetes related complications. Relevant history was taken and directed physical examination was performed. All patients underwent routine blood investigations, OGTT, HbA1c and were screened for retinopathy, nephropathy and neuropathy. Those with deranged values were followed and counselled and advised for further management. Of the 187 patients studied, 53.47% were males and 46.53% were females. Most of the patients(~83%) were in the age group 30-50 years with mean age of 46yrs. Around 45% patients had positive family history of DM of which ~25% had positive history of DM in both parents and ~20% with single parent history. Positive family history of Hypertension was found in 40.1% and positive family history of both hypertension and T2DM in 12.29% subjects. Microvascular complications like Neuropathy was observed in 25.13%, Nephropathy in 25.13%, Retinopathy in 24.06% of subjects. With poor glycemic control conferred higher risk of complications. Nephropathy, Retinopathy and Neuropathy were present in 60%, 46.6%, 13.3% subjects respectively when HbA1c was between 8.51-9.5%. Strict glycemic control does count even in newly diagnosed type 2 diabetics to prevent and minimize the occurrence of complications.